Tom Böhling

<i>MED12</i> , the <i>Mediator Complex Subunit 12</i> Gene, Is Mutated at High Frequency in Uterine Leiomyomas

Netta Mäkinen, Miika Mehine, Jaana Tolvanen et al. · Science · 2011 · 660 citations

Medicine, Molecular Biology, Molecular Genetics +17

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts

Juha Paloneva, Marjo Kestilä, Jun Wu et al. · Nature Genetics · 2000 · 472 citations

Medicine, Genetics, Neurology +15

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 435 citations

Medicine, Oncology, Surgery +17

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan et al. · Journal of Clinical Oncology · 2015 · 421 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

Jeremy Whelan, Stefan Bielack, Neyssa Marina et al. · Annals of Oncology · 2014 · 333 citations · Full text

Medicine, Oncology, Surgery +15